retatrutide approval status october 2025 27, 2025: U.K. regulators bust illicit site making unlicensed and tirzepatide pens – Partnership for Safe Medicines Retatrutide: FDA approval time, trial

Patient awareness campaigns and digital health platforms are increasing treatment-seeking behavior among urban populations with obesity concerns

Women over 40 respond well to GLP-1s and other weight-loss medications clinical trial data shows comparable efficacy across age groups

Continuous glucose monitoring, wearable devices, and AI-driven analytics are enabling real-time insights

Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX, Twomey D, Elliott AD, Kalman JM, Abhayaratna WP, Lau DH, Sanders P (2015) Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)

D.ChoiS.-Y.FrohmanM